20 April 2026
Perodua Manufacturing directs panel clinics to stop prescribing GLP-1 and GIP/GLP-1 shots for diabetes to staff, pending further evaluation, and to prescribe other oral hypoglycaemic drugs instead. GLP-1 and GIP/GLP-1 meds treat both diabetes and obesity.